Combination of Thrombolysis and Glycoprotein IIb/IIIa Inhibition in Chronic Peripheral Thrombosis: A Case Report
Journal Title: International Journal of Radiology and Radiation Oncology - Year 2017, Vol 3, Issue 1
Abstract
Currently, many interventionalists employ either tissue plasminogen activator (alteplase, Genentech, San Francisco, CA), or recombinant plasminogen activator (reteplase, Chiesi USA, Inc., Cary, NC), for peripheral thrombolysis. Further, combination therapy utilizing a thrombolytic agent and a glycoprotein IIb/IIIa receptor antagonist has been proposed as a way to overcome the limitations of thrombolytic therapy alone by reducing the duration of infusion, preventing rethrombosis, and improving the efficacy of thrombolysis. The following report discusses a patient with stenoses in the distal right posterior tibial artery. The patient underwent percutaneous transluminal angioplasty along with tissue plasminogen activator infusion therapy. Initially, the tissue plasminogen activator infusion reduced pain. However, an embolic occlusion to the distal right lateral plantar artery led to recurrence of pain. Due to failure of thrombolytic monotherapy using tissue plasminogen activator, a combined treatment of eptifibatide (Integrilin, Cor Therapeutics and Schering-Plough) and tissue plasminogen activator infused intra-arterially was initiated. In this report, the successful clinical use of combination therapy has been demonstrated after failed intra-arterial tissue plasminogen activator infusion monotherapy. The use of purely intra-pedal intra-arterial eptifibatide is novel and should be studied in randomized trials to establish efficacy. Furthermore, we have shown that failure of monotherapy to treat occlusions can be recovered through the use of combination therapy.
Authors and Affiliations
Syed Mubin I, Gallagher Ryan, Hussain Zeshan, Shaikh Azim, Cain Philip J, Morar Kamal, Guehl Allen, Erdelyi Ronald
Keywords
Related Articles
- EP ID EP541303
- DOI 10.17352/ijrro.000020
- Views 54
- Downloads 0
Adenoid Cystic Carcinoma of the Maxilla, CT Follow-Up: A Case Report
Background: Intraoral adenoid cystic carcinoma is an uncommon pathology with a variable clinical course, it develops as a slow growing swelling characterized by wide local infiltration. Most patients are in their fourth...
Successful Treatment of a Bilateral Lower Palpebral MALT Lymphoma with Rapid Arc: Description of a New Technique
Primary MALT lymphoma of the eyelids is a rare disease; chronic infection by Chlamydophila psittaci has been identified as a possible causative agent, but other pathogens may be implicated such Hepatitis C virus and Heli...
Application of Cone Beam Computed Tomography to Conventional Radiotherapy: Limited Angle of Projections for Lymph Nodes Located above or below the Collarbone
Various techniques are used in image-guided radiotherapy (IGRT). Cone beam computed tomography (CBCT) is widely used in IGRT on linear accelerators. The increased accuracy of IGRT enables reducing planning target volume...
A comparative evaluation of two head and neck immobilization devices using verification film for head and neck cancer patients receiving radiation therapy at Ocean Road Cancer Institute (ORCI) aero-digestive tract
Background: Accurate and reproducible patient positioning is fundamental to the success of fractionated radiotherapy. To achieve accurate daily treatment delivery, various immobilization devices are used in radiotherapy...
Timing of Annual Output Calibration of Radiotherapy Linear Accelerators
The output of radiotherapy Linear Accelerators (Linacs) is calibrated following national or international protocols like TG-51 by the American Association of Physicists in Medicine [1] or TRS-398 by the International Ato...